168 related articles for article (PubMed ID: 16262589)
1. Naltrexone treatment of adolescent alcoholics: an open-label pilot study.
Deas D; May MP; Randall C; Johnson N; Anton R
J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):723-8. PubMed ID: 16262589
[TBL] [Abstract][Full Text] [Related]
2. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
[TBL] [Abstract][Full Text] [Related]
3. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone utility in depressed alcoholics.
Salloum IM; Cornelius JR; Thase ME; Daley DC; Kirisci L; Spotts C
Psychopharmacol Bull; 1998; 34(1):111-5. PubMed ID: 9564207
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
Galloway GP; Koch M; Cello R; Smith DE
BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study.
Yoon G; Kim SW; Thuras P; Westermeyer J
Hum Psychopharmacol; 2011 Mar; 26(2):125-32. PubMed ID: 21437991
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone in patients with bipolar disorder and alcohol dependence.
Brown ES; Beard L; Dobbs L; Rush AJ
Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
[TBL] [Abstract][Full Text] [Related]
13. Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders.
Batki SL; Dimmock JA; Wade M; Gately PW; Cornell M; Maisto SA; Carey KB; Ploutz-Snyder R
Am J Addict; 2007; 16(4):253-9. PubMed ID: 17661192
[TBL] [Abstract][Full Text] [Related]
14. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
[TBL] [Abstract][Full Text] [Related]
16. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.
de Laat B; Goldberg A; Shi J; Tetrault JM; Nabulsi N; Zheng MQ; Najafzadeh S; Gao H; Kapinos M; Ropchan J; O'Malley SS; Huang Y; Morris ED; Krishnan-Sarin S
Biol Psychiatry; 2019 Dec; 86(11):864-871. PubMed ID: 31399255
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
18. Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale.
Roberts JS; Anton RF; Latham PK; Moak DH
Alcohol Clin Exp Res; 1999 Sep; 23(9):1484-91. PubMed ID: 10512314
[TBL] [Abstract][Full Text] [Related]
19. The A-OCDS predicts both craving and alcohol cue reactivity in adolescent alcoholics.
Thomas SE; Deas D
Addict Behav; 2005 Oct; 30(9):1638-48. PubMed ID: 16140462
[TBL] [Abstract][Full Text] [Related]
20. Reductions in and relations between "craving" and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
Dawes MA; Johnson BA; Ma JZ; Ait-Daoud N; Thomas SE; Cornelius JR
Addict Behav; 2005 Oct; 30(9):1630-7. PubMed ID: 16084024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
